US$ 21.20
new indications for glp 1 drugs fda What to know about the era of GLP-1 Can one drug do it
Description
Unfortunately, she continues to suffer from gastroparesis, which has no cure, and requires consistent medical care

Keywords: diabetes, pancreatic cancer, GLP-1 receptor agonists 1

On the other hand, the recent bidding war between Pfizer and Novo Nordisk for Metsera (NASDAQ: MTSR) GLP-1s provides another signal regarding the markets direction

Longer-term concerns include a potential increased risk of pancreatitis, bowel obstruction, and thyroid cancer
[DOI] [PMC free article] [PubMed] [Google Scholar] 52.Singh G, Krauthamer M, Bjalme-Evans M